If you are interested in learning more about your possible participation in this clinical trial, please complete the form. Your information will be forwarded directly to the sponsoring company.
- Study participants must have histologically confirmed solid tumors or lymphomas or myelodysplastic syndromes that have progressed on standard therapy known to prolong survival or for which no standard treatment options exist
- Age greater than or equal to 18
- No major surgery, radiation, or chemotherapy within 3 weeks prior to entering the study
- Adequate organ function